National Association of Testing Authorities, Australia
Scope of Accreditation
Microbiological Diagnostic Unit, Public Health Laboratory - University of Melbourne
Site
The University of Melbourne – At the Peter Doherty Institute for Infection & Immunity
Accreditation No.
1019
Site No.
3284
Date of Accreditation
28 Oct 1991
Address
Department of Microbiology and Immunology, At the Peter Doherty Institute for Infection and Immunity, Level 1, 792 Elizabeth St (cnr of Grattan and Elizabeth St)
Melbourne, VIC 3000
Australia
Contact
Ms Selena Heaton
P: +61 (03) 83445701
Availability
Services available to external clients
Supervision
S (Specialised)
Scope of Accreditation
The University of Melbourne – At the Peter Doherty Institute for Infection & Immunity
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
04 Jul 2026
Last Activity Date
17 Aug 2023
| Service | Product | Determinant |
|---|---|---|
| Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Axilla swabs; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Genital swabs; Nasal swabs; Nasopharyngeal swabs; Perineum swabs; Rectal swabs; Skin; Throat swabs; Urine; Vomitus; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility |
| Aspirates; General swabs | Bacteria; Pathogenic microorganisms | |
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Bacterial isolates | Neisseria gonorrhoeae; Neisseria gonorrhoeae outer membrane protein (OMP); Neisseria meningitidis; Neisseria meningitidis - Encapsulated; Neisseria meningitidis polysaccharide capsule antigen; Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Antibiotic susceptibility | ||
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Antibiotic susceptibility | ||
| Haemophilus influenzae | ||
| Bacterial isolates; Faeces | Bacteria; Pathogenic identification; Pathogenic microorganisms | |
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Faeces | Detection and characterisation of bacteria (including identification and typing) |
| Human clinical samples; Isolates | Detection and characterisation of bacteria (including identification and typing) | |
| Isolates | Detection and characterisation of bacteria (including identification and typing) | |
| Microbiology - Environmental investigations and/or infection control | Air; Blood transfusion bags; Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Microfilter discs; Spore strips; Vascular catheter tips; Waters | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) |
| Microbiology - Molecular biology - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Cervical swabs; Rectal swabs; Urine; Vaginal swabs | Chlamydia trachomatis; Fluoroquinolone resistant Mycoplasma genitalium |
| Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Eye swabs; Faeces; Genital swabs; Rectal swabs; Synovial fluid; Tissues; Urine; Wound swabs | Burkholderia spp.; Chlamydia trachomatis; Chlamydia trachomatis serovars L1, L2, L2a or L3 (LGV); Escherichia coli STEC stx1/stx2; Haemophilus influenzae; Listeria spp.; Mycoplasma genitalium; Neisseria gonorrhoeae; Neisseria gonorrhoeae Opa; Neisseria gonorrhoeae PorA; Neisseria meningitidis; Neisseria meningitidis FetA VR typing; Neisseria meningitidis PorA; Neisseria meningitidis PorB; Streptococcus pneumoniae; Streptococcus pyogenes EMM typing | |
| Bacterial isolates | Bacillus anthracis; Burkholderia cepacia complex; Burkholderia pseudomallei; Campylobacter jejuni; Campylobacter spp.; Clostridium tetani; Corynebacterium diphtheriae; Enterococcus faecalis; Enterococcus faecium; Enterococcus spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enteropathogenic (EPEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli; Haemophilus influenzae; Haemophilus influenzae typing; Haemophilus spp.; Klebsiella pneumoniae; Legionella pneumophila; Listeria monocytogenes; Mycoplasma hominis; Neisseria gonorrhoeae; Neisseria meningitidis; Neisseria meningitidis - Encapsulated; Salmonella spp.; Shigella spp.; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Vibrio cholerae; Vibrio spp.; Antibiotic resistance gene detection; Methicillin resistant Staphylococcus aureus (MRSA); PorA | |
| Cerebrospinal fluid (CSF); Faeces | Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli K1; Escherichia coli STEC stx1/stx2; Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis - Encapsulated; Plesiomonas shigelloides; Salmonella spp.; Shigella spp.; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus; Yersinia enterocolitica; Shiga toxin; Toxin gene detection | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human herpes virus type 6 (HHV6); Human parechovirus; Varicella zoster virus (VZV) |
| Faeces | Adenovirus; Astrovirus; Norovirus; Rotavirus; Sapovirus | |
| Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Extracted DNA; Purified PCR product | Sequenced DNA by Sanger sequencing; Sequenced DNA utilising massively parallel sequencing technologies |
| Microbiology - Molecular biology - Microbial genotyping by whole genome sequencing studies | DNA; Isolates | Drug resistance Mycobacterium tuberculosis |
| Microbiology - Molecular biology - Public health investigation and/or monitoring | Amniotic fluid; Aspirates; Bacterial isolates; Blood; Bronchial swabs; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Cervical specimen; Cervical swabs; Dry swabs; Eye swabs; Faeces; Genital swabs; Human clinical samples; Liquid based cytology specimens; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Non-human clinical isolates; Paraffin embedded tissue; Pericardial fluid; Plasma; Pleural fluid; Rectal swabs; Respiratory specimens; Semen; Serum; Sputum; Sterile site; Tampons; Throat swabs; Tissues; Tonsil swabs; Urethral swabs; Urine; Vaginal swabs; Wound swabs | Detection and characterisation of organisms (including identification and typing); Organism characterisation for patient management |
| Microbial nucleic acids | Phylogenetic analysis | |
| Microbiology - Parasitology - Public health investigation and/or monitoring | Faeces | Detection and characterisation of parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Bunyaviridae spp.; Clostridium perfringens enterotoxin; Cryptosporidium antigen; Giardia antigen |
| Serum | Entamoeba histolytica | |
| Yersinia spp. IgG antibody; Yersinia spp. | ||
| Corynebacterium diphtheriae; Tetanus |
Mobile Testing
ISO 15189 (2012)
Human Pathology
Medicare expiry date
04 Jul 2026
Last Activity Date
17 Aug 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols - Mobile testing | Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Microbiology - Virology - Surveillance screening programme for the antigenic detection of pathogenic viruses as directed by Commonwealth/State Health Departments to support public health testing - Mobile testing service | Nasal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
1019
Site No.
3284
Print date
27 Apr 2024
END OF SCOPE
